Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

After the London tragedy, is it still possible to consider Phase I is safe?

Sibille M, Donazzolo Y, Lecoz F, Krupka E.

Br J Clin Pharmacol. 2006 Oct;62(4):502-3. Epub 2006 Jul 3. No abstract available.

2.

Systemic and regional hemodynamic and biological effects of a new kappa-opioid agonist, niravoline, in healthy volunteers.

Bellissant E, Denolle T, Sinnassamy P, Bichet DG, Giudicelli JF, Lecoz F, Gandon JM, Allain H.

J Pharmacol Exp Ther. 1996 Jul;278(1):232-42.

PMID:
8764356
3.

[Delay in the effect of antidepressive agents: pharmacologic approach].

Allain H, Masson AV, Bentue-Ferrer D, Toulouse P, Lecoz F.

Encephale. 1995 Mar;21 Spec No 2:9-15. Review. French.

PMID:
7588184
4.

Relationships between acute and chronic beta-blocking effects of bisoprolol in healthy volunteers: a practical approach to predict intensity of beta-blockade.

Jamin P, LeCoz F, Funck-Brentano C, Poirier JM, Jaillon P.

J Cardiovasc Pharmacol. 1994 Apr;23(4):658-63.

PMID:
7516019
5.

Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects.

Allain H, Raoul P, Lieury A, LeCoz F, Gandon JM, d'Arbigny P.

Clin Ther. 1993 May-Jun;15(3):549-58.

PMID:
8364946
6.

Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients.

Rames A, Poirier JM, LeCoz F, Midavaine M, Lecocq B, Grange JD, Poupon R, Cheymol G, Jaillon P.

Clin Pharmacol Ther. 1990 Mar;47(3):354-9.

PMID:
2178853

Supplemental Content

Support Center